US$ 24.00
hydration benefits glp-1 receptor agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Receptor Agonists as Treatments
Description
2026 ( Frontiers in Endocrinology ), Managing nausea and vomiting in GLP-1-based obesity therapies

( 1 ) For men seeking new weight loss solutions, GLP-1 is likely at the top of mind

Lancet 402 , 203234 (2023)

Appetite suppression, delayed gastric emptying, and altered absorption are all considered plausible contributors to increased micronutrient deficiency risk

declares a research grant from Eli Lilly and Company to his institution to perform the work described in this paper and research grants from NIH and Nestle, Inc., and has served on advisory boards for Novo Nordisk

Errors or sequence variants can lead to ineffective treatments or adverse effects
